{"id":"clm_D4E43C41EA53","entity":"preferred-networks","predicate":"partnership","value":"Kao Corporation","value_json":{"feed":"preferred-networks-news","item":"https://www.preferred.jp/en/news/pr20191120","tags":{"v":2,"ai":true,"by":"claude-haiku-5-5","on":"2026-11-09","deal":{"kind":"partnership","purpose":"research_safety","counterparty":"Kao Corporation","counterparty_type":"other"},"themes":["health_science"]},"check":{"on":"2026-11-09","url":"https://www.preferred.jp/en/news/pr20191120","pages":1,"quote":"November 20, 2019, Tokyo Japan – Kao Corporation and Preferred Networks, Inc. launch a collaborative project named “Kao X PFN Sebum RNA Project” with the objective of putting into practical use the technology which Kao has developed to monitor RNA (ribonucleic acid) in sebum.","outcome":"checked"},"evidence":"November 20, 2019, Tokyo Japan – Kao Corporation and Preferred Networks, Inc. launch a collaborative project named “Kao X PFN Sebum RNA Project” with the object","extracted_by":"claude-haiku-5-5","primary_source":true},"valid_from":"2019-11-20","valid_to":null,"published":"2019-11-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Preferred Networks partnership: Kao Corporation\", as of 2019-11-20. Claim clm_D4E43C41EA53, https://asof.is/claim/clm_D4E43C41EA53, accessed 2026-11-10. Source: https://www.preferred.jp/en/news/pr20191120.","url":"https://asof.is/claim/clm_D4E43C41EA53","accessed":"2026-11-10"},"confidence":0.7,"status":"valid","assertable":true,"superseded_by":null,"supersedes":[],"first_seen_at":"2026-11-08T19:52:43.461495+00:00","updated_at":"2026-11-09T13:35:29.480492+00:00","sources":[{"url":"https://www.preferred.jp/en/news/pr20191120","tier":"primary","publisher":"Preferred Networks","published_at":"2019-11-19T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-09","quote":"November 20, 2019, Tokyo Japan – Kao Corporation and Preferred Networks, Inc. launch a collaborative project named “Kao X PFN Sebum RNA Project” with the objective of putting into practical use the technology which Kao has developed to monitor RNA (ribonucleic acid) in sebum.","url":"https://www.preferred.jp/en/news/pr20191120","excerpt":"November 20, 2019, Tokyo Japan – Kao Corporation and Preferred Networks, Inc. launch a collaborative project named “Kao X PFN Sebum RNA Project” with the object"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"page-read":"its source page states the value and the date"}}}